InvestorsHub Logo
Followers 4
Posts 145
Boards Moderated 0
Alias Born 01/08/2022

Re: Jonjones325 post# 349922

Monday, 02/07/2022 9:55:19 PM

Monday, February 07, 2022 9:55:19 PM

Post# of 457537
I agree Jonjones325. The Anavex Leadership needs to step up its communication. Let the public know what is occuring/changing in regards to Trials and Corporate decisions that impact the stock good or bad. I understand the need to keep certain decisions under wrap until it is the right time to release. Sometimes you need to verify and verify again before you release information.

I am wondering if the Australian Heath practitioners are using Compassionate Use Special Access Scheme Approval for Alzheimer's Patients to use Anavex 2-73 which has not yet been approved in Australia.

I think it would be nice to know the numbers of patients using Anavax 2-73 under SAS at each quarterly conference call. If the numbers are meaningful.

This Msg Board just had numerous post discussing the fact that in Australia it is well known that 2-73 works. If I was a practitioner and new the drug was safe and works I would want my patient to have access. This also goes back to the devastated families that learn they have that horrible disease. I have read plenty and families need hope above all else.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News